Purification and functional reconstitution with GTP-binding regulatory proteins of hexahistidine-tagged muscarinic acetylcholine receptors (m2 subtype)

被引:0
作者
Hayashi, MK
Haga, T
机构
关键词
G-protein; histidine-tag; muscarinic receptor; purification;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have expressed human m2 muscarinic acetylcholine receptors tagged with six histidine residues at the carboxy-terminal region in insect cells (Sf9) and purified them using metal-immobilized Chelating Sepharose gels. Co2+-immobilized gels were found to be much more efficient for purification of m2 receptors than gels containing Ni2+ or other metal ions, Twenty-fold purification was attained by a simple, single-step procedure, and approximately 40% of solubilized receptors were recovered as a partially purified preparation with a specific activity of 1.6 nmol/mg of protein. Purified receptors were functionally active in that carbamylcholine stimulated binding of [S-35]GTP gamma S to the G-protein G(12) reconstituted in lipid vesicles with purified m2 receptors, The extent of stimulation of [S-35]GTP gamma S binding to G(12) by hexahistidine-tagged m2 receptors was essentially the same as that observed for m2 receptors that lack histidine tags, In addition, palmitoylation at the carboxy-terminal region was not impaired by the hexahistidine-tag fusion, The method described in this study should be applicable to the purification of other G-protein-coupled receptors in functionally active form.
引用
收藏
页码:1232 / 1238
页数:7
相关论文
共 44 条
[1]  
BENOVIC JL, 1990, RECEPTOR BIOCH PRACT, P125
[2]   MAPPING OF SINGLE AMINO-ACID-RESIDUES REQUIRED FOR SELECTIVE ACTIVATION OF G(Q/11) BY THE M3 MUSCARINIC ACETYLCHOLINE-RECEPTOR [J].
BLIN, N ;
YUN, J ;
WESS, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17741-17748
[3]   INSERTION MUTAGENESIS AS A TOOL TO PREDICT THE SECONDARY STRUCTURE OF A MUSCARINIC RECEPTOR DOMAIN DETERMINING SPECIFICITY OF G-PROTEIN COUPLING [J].
BLUML, K ;
MUTSCHLER, E ;
WESS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :7980-7984
[4]  
BOUNDY VA, 1993, J PHARMACOL EXP THER, V264, P1002
[5]  
BOUVIER M, 1995, METHOD ENZYMOL, V250, P300
[6]  
Crowe J, 1994, Methods Mol Biol, V31, P371
[7]  
DEMOLIOUMASON CD, 1990, RECEPTOR BIOCH PRACT, P99
[8]  
HAGA K, 1986, J BIOL CHEM, V261, P133
[9]  
HAGA K, 1985, J BIOL CHEM, V260, P7927
[10]  
HAGA T, 1990, RECEPTOR BIOCH PRACT, P1